BRPI0911073A2 - alterações específicas para o mal de alzheimer da razão de fosforilação erk1/erk2 - biomarcadores moleculares específicos ao mal de alzheimer (adsmb) - Google Patents

alterações específicas para o mal de alzheimer da razão de fosforilação erk1/erk2 - biomarcadores moleculares específicos ao mal de alzheimer (adsmb)

Info

Publication number
BRPI0911073A2
BRPI0911073A2 BRPI0911073A BRPI0911073A BRPI0911073A2 BR PI0911073 A2 BRPI0911073 A2 BR PI0911073A2 BR PI0911073 A BRPI0911073 A BR PI0911073A BR PI0911073 A BRPI0911073 A BR PI0911073A BR PI0911073 A2 BRPI0911073 A2 BR PI0911073A2
Authority
BR
Brazil
Prior art keywords
alzheimer
specific
adsmb
erk1
disease
Prior art date
Application number
BRPI0911073A
Other languages
English (en)
Portuguese (pt)
Inventor
L Alkon Daniel
Kumar Khan Tapan
Original Assignee
Blanchette Rockefeller Neurosciences Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/078,857 external-priority patent/US20080221042A1/en
Application filed by Blanchette Rockefeller Neurosciences Inst filed Critical Blanchette Rockefeller Neurosciences Inst
Publication of BRPI0911073A2 publication Critical patent/BRPI0911073A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0911073A 2008-04-07 2009-04-03 alterações específicas para o mal de alzheimer da razão de fosforilação erk1/erk2 - biomarcadores moleculares específicos ao mal de alzheimer (adsmb) BRPI0911073A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/078,857 US20080221042A1 (en) 2005-10-11 2008-04-07 Alzheimer's disease-specific alterations of the ERK1/ERK2 Phosphorylation ratio-Alzheimer's disease-specific molecular biomarkers (ADSMB)
PCT/US2009/002120 WO2009126232A1 (en) 2008-04-07 2009-04-03 Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (adsmb)

Publications (1)

Publication Number Publication Date
BRPI0911073A2 true BRPI0911073A2 (pt) 2019-09-24

Family

ID=41037627

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911073A BRPI0911073A2 (pt) 2008-04-07 2009-04-03 alterações específicas para o mal de alzheimer da razão de fosforilação erk1/erk2 - biomarcadores moleculares específicos ao mal de alzheimer (adsmb)

Country Status (9)

Country Link
EP (1) EP2263090A1 (zh)
JP (1) JP2011516883A (zh)
KR (1) KR20100132997A (zh)
AU (1) AU2009234405A1 (zh)
BR (1) BRPI0911073A2 (zh)
CA (1) CA2720621A1 (zh)
IL (1) IL208296A0 (zh)
TW (1) TW200942819A (zh)
WO (1) WO2009126232A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3090261B8 (en) * 2014-01-03 2019-06-26 The West Virginia University Board of Governors on behalf of West Virginia University Convergence of aggregation rate with validated peripheral diagnostics for alzheimer's disease
US11415574B2 (en) 2017-03-31 2022-08-16 NeuroDiagnostics LLC Lymphocyte-based morphometric test for alzheimer's disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007043998A1 (en) * 2005-10-11 2007-04-19 Blanchette Rockefeller Neurosciences Institute Alzheimer’s disease-specific alterations of the erk1/erk2 phosphorylation ratio

Also Published As

Publication number Publication date
TW200942819A (en) 2009-10-16
AU2009234405A1 (en) 2009-10-15
KR20100132997A (ko) 2010-12-20
JP2011516883A (ja) 2011-05-26
WO2009126232A1 (en) 2009-10-15
EP2263090A1 (en) 2010-12-22
IL208296A0 (en) 2010-12-30
CA2720621A1 (en) 2009-10-15

Similar Documents

Publication Publication Date Title
DE602006020674D1 (de) Polymerzusammensetzung
DK1838736T3 (da) Cripto-bindende molekyler
BRPI0818789A2 (pt) Medição de rendimento elétrico para centros de dados.
BRPI0812310A2 (pt) Componente de mancal, mancal de rolamento e mancal de deslizamento
DE602007011183D1 (de) Hydrazinfunktionalisiertes Polymer
BRPI0813128A2 (pt) Conjunto de conexão e eixo cardã
DE602007012549D1 (de) Vulkanisat enthaltend azin-funktionalisiertes polymer
BRPI0907637A2 (pt) Biomarcadores p53
DE602008001230D1 (de) Verbesserte Polymerzusammensetzung
DE602008005522D1 (de) Polymerlösungen
DE602008004814D1 (de) Bläserwellenrückhaltung
ITMI20051569A1 (it) Composizione cicatrizzante
BRPI0807980A2 (pt) Polímero de não-polialfaolefinas dispersos para redução de arraste
ATE404837T1 (de) Kondensationsanlage
BRPI0818669A2 (pt) formulação para melhora da função gastrintestinal
BRPI0811591A2 (pt) Pneumático com armadura de carcaça radial
ATE445653T1 (de) Säuregruppenhaltige kondensationsprodukte
DE502007000089D1 (de) Elastisches Fahrwerkslager
BRPI0911073A2 (pt) alterações específicas para o mal de alzheimer da razão de fosforilação erk1/erk2 - biomarcadores moleculares específicos ao mal de alzheimer (adsmb)
BRPI0920204A2 (pt) chapa de suporte para mancal
ITMI20060096U1 (it) Involucro da spedizione
DK1877102T3 (da) Tab-molekyler
FR2880661B1 (fr) Module de roulement
BRPI0815608A2 (pt) Determinação de latência de servidor de conteúdo
ATE420331T1 (de) Kondensationsanlage

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.